Rigel Pharmaceuticals (RIGL)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Rigel Pharmaceuticals-Aktie (RIGL)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	17.48% 29.53	35.79	28.13	26.89	26.07
Cost Of Revenue	46.57% 2.025	3.79	1.268	1.075	0.977
Gross Profit	14.04% 27.51	32.00	26.87	25.81	25.09
Operating Expenses	14.78% 34.48	30.04	31.33	31.08	37.82
Interest Income/Expense	1.73% 1.874	1.907	1.899	1.862	1.204
Benefits Costs and Expenses	7.78% 37.78	35.05	32.60	32.15	39.61
Costs And Expenses	7.91% 36.50	33.83	32.60	32.15	38.80
Operating Income/Loss	454.32% -6.966	1.966	-4.465	-5.267	-12.72
Income/Loss From Continuing Operations Before Tax	1,219% -8.247	0.737	-4.465	-6.60	-13.54
Income/Loss From Continuing Operations After Tax	1,219% -8.247	0.737	-5.692	-6.60	-13.54
Net Income/Loss	1,219% -8.247	0.737	-5.692	-6.60	-13.54
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	145.90K% 175.20	0.12	174.36	173.75	173.57
Diluted Average Shares	145.90K% 175.20	0.12	174.36	173.75	173.57
Basic Earnings Per Share	600.00% -0.05	0.010	-0.03	-0.04	-0.08
Diluted Earnings Per Share	600.00% -0.05	0.010	-0.03	-0.04	-0.08
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$18.98

3.66%

INCY

$76.97

1.45%

MRNA

$39.51

7.22%

UTHR

$359.21

1.11%

BGNE

$187.69

0.81%

BNTX

$101.87

2.16%